Nalossone [Dcit] en es it fr

Nalossone [Dcit] Brand names, Nalossone [Dcit] Analogs

Nalossone [Dcit] Brand Names Mixture

  • No information avaliable

Nalossone [Dcit] Chemical_Formula


Nalossone [Dcit] RX_link

Nalossone [Dcit] fda sheet

Nalossone [Dcit] msds (material safety sheet)

Nalossone_[Dcit] MSDS

Nalossone [Dcit] Synthesis Reference

No information avaliable

Nalossone [Dcit] Molecular Weight

327.374 g/mol

Nalossone [Dcit] Melting Point

200 - 205 oC

Nalossone [Dcit] H2O Solubility


Nalossone [Dcit] State


Nalossone [Dcit] LogP


Nalossone [Dcit] Dosage Forms


Nalossone [Dcit] Indication

For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.

Nalossone [Dcit] Pharmacology

Naloxone is an opiate antagonist and prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Naloxone is an essentially pure narcotic antagonist, i.e., it does not possess the "agonistic" or morphine-like properties characteristic of other narcotic antagonists; naloxone does not produce respiratory depression, psychotomimetic effects or pupillary constriction. In the absence of narcotics or agonistic effects of other narcotic antagonists, it exhibits essentially no pharmacologic activity.

Nalossone [Dcit] Absorption

Well absorbed following intramuscular injection.

Nalossone [Dcit] side effects and Toxicity

No information avaliable

Nalossone [Dcit] Patient Information

No information avaliable

Nalossone [Dcit] Organisms Affected

Humans and other mammals